$RXST Income Statement | Understand Stock

$RXST

$4.93 -$0.09 (1.79%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Sales
Cost of sales
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
Total operating expenses
Loss from operations
Other income (expense), net:
Change in fair value of warrants
Expiration of warrant
Interest expense
Interest and other income
Loss on extinguishment of term loan

Loss before income taxes
Income tax expense
Net loss
Net loss attributable to common stockholders
Other comprehensive (loss) income
Unrealized (loss) gain on short-term investments
Foreign currency translation gain (loss)
Total other comprehensive (loss) income
Comprehensive loss
Net loss per share:
Attributable to common stock, basic
Attributable to common stock, diluted
Weighted-average shares outstanding used in computing net loss per share:
Attributable to common stock, basic
Attributable to common stock, diluted

Comments